SYSTEM; LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEM; LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEM; LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEM; LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Off-the-Shelf' cell therapy trial targets six severe autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new cell therapy called BCT301 for people with severe autoimmune diseases that haven't responded to standard treatments. The therapy uses lab-made immune cells designed to target and remove harmful B cells, which are thought to drive these dise…
Matched conditions: SYSTEM; LUPUS ERYTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Blood test breakthrough could end diagnostic confusion for bleeding disorders
Diagnosis Not yet recruitingThis study aims to find a better way to tell apart two similar conditions that cause low platelets and bleeding risk: primary immune thrombocytopenia (ITP) and low platelets caused by lupus (SLE). Researchers will test blood samples from 300 adults to see if measuring levels of t…
Matched conditions: SYSTEM; LUPUS ERYTHEMATOSUS
Sponsor: Sohag University • Aim: Diagnosis
Last updated Mar 16, 2026 15:24 UTC